DWJ 1386Alternative Names: DWJ1386
Latest Information Update: 18 Jan 2017
At a glance
- Originator Daewoong Pharmaceutical
- Class Antiulcers
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Gastrointestinal ulcer
Most Recent Events
- 01 Feb 2016 Phase-I clinical trials in Gastrointestinal ulcer (In volunteers) in South Korea (PO) (NCT03016494)